Embecta Corp (EMBC NASDAQ) stock market data APIs
$9.6969
-0.12(-1.2%)
as of June 30, 2025
Try our APIs with
free plan!
Embecta Corp Financial Data Overview
Price chart is built with
Anychart
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Prev. Close
9.6969
Open
9.5738
High
9.6615
Low
9.4441
52 wk Range
9.2-20.7985
Market Cap
563 M
P/E Ratio
10.8315
Shares Outstanding
58 443 K
Revenue
1 080 M
EPS
0.7
Dividends (Yield)
0.0622
Beta
1.077
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Embecta Corp data using free add-ons & libraries
Get Embecta Corp Fundamental Data
Embecta Corp Fundamental data includes:
- Net Revenue: 1 080 M
- EBITDA: 83 800 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-07
- EPS/Forecast: 0.5875
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Embecta Corp News
New
Embecta Corp. (EMBC) Lowered FY25 Guidance Amid Foreign Exchange Challenges
River Road Asset Management, an investment management company, released its “River Road Small Cap Value Fund” Q1 2025 investor letter. A copy of the letter can be downloaded here. In the first qua...
embecta to Participate in Investor Events
PARSIPPANY, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medica...
embecta to Showcase Phased Approach for Value Creation and Present Long Range Financial Plan at 2025 Analyst and Investor Day
PARSIPPANY, N.J., May 22, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta"; "The Company") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host its i...
Embecta restructures again, outlines tariff costs
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Embecta began a restructuring plan in its fiscal second q...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
